BEGIN:VCALENDAR
VERSION:2.0
PRODID:spatie/icalendar-generator
DESCRIPTION:Events from Ann Arbor Observer
X-WR-CALDESC:Events from Ann Arbor Observer
REFRESH-INTERVAL;VALUE=DURATION:PT1440M
X-PUBLISHED-TTL:PT1440M
BEGIN:VTIMEZONE
TZID:America/Detroit
BEGIN:STANDARD
DTSTART:20251102T020000Z
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20260308T020000Z
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
DTSTART:20250713T231155Z
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:61398-60618
DTSTAMP:20260409T231155Z
SUMMARY:Challenges in Trial Design for Psychedelic-Assisted Therapies
LOCATION:
ORGANIZER;CN=Jen Taylor:MAILTO:jen@aaobserver.com
DTSTART;TZID=America/Detroit:20260409T160000
DTEND;TZID=America/Detroit:20260409T170000
X-ALT-DESC;FMTTYPE=TEXT/HTML:Fueled by positive findings from clinical tria
 ls\, psychedelic research has returned to mainstream psychiatry and neuros
 cience\, with a growing number of studies examining a wide range of condit
 ions. However\, expectancy effects and effective condition blinding have b
 een raised as critical limitations to the interpretability of this researc
 h. In this talk\, Jacob Aday\, PhD\, will review&hellip\;
CATEGORIES:Community Listing,  Free
URL;VALUE=URI:https://annarborobserver.com/mc-events/challenges-in-trial-de
 sign-for-psychedelic-assisted-therapies/
METHOD:PUBLISH
END:VEVENT
END:VCALENDAR